Logo image of GBCI

GLACIER BANCORP INC (GBCI) Stock Fundamental Analysis

NYSE:GBCI - New York Stock Exchange, Inc. - US37637Q1058 - Common Stock - Currency: USD

46.19  -0.47 (-1.01%)

After market: 46.19 0 (0%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to GBCI. GBCI was compared to 397 industry peers in the Banks industry. GBCI has a bad profitability rating. Also its financial health evaluation is rather negative. GBCI is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

GBCI had positive earnings in the past year.
GBCI had a positive operating cash flow in the past year.
In the past 5 years GBCI has always been profitable.
GBCI had a positive operating cash flow in each of the past 5 years.
GBCI Yearly Net Income VS EBIT VS OCF VS FCFGBCI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

1.2 Ratios

GBCI has a Return On Assets (0.76%) which is in line with its industry peers.
The Return On Equity of GBCI (6.45%) is worse than 66.25% of its industry peers.
Industry RankSector Rank
ROA 0.76%
ROE 6.45%
ROIC N/A
ROA(3y)0.87%
ROA(5y)1.03%
ROE(3y)7.98%
ROE(5y)8.89%
ROIC(3y)N/A
ROIC(5y)N/A
GBCI Yearly ROA, ROE, ROICGBCI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

GBCI's Profit Margin of 24.68% is in line compared to the rest of the industry. GBCI outperforms 56.17% of its industry peers.
GBCI's Profit Margin has declined in the last couple of years.
GBCI does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 24.68%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-13.51%
PM growth 5Y-7.22%
GM growth 3YN/A
GM growth 5YN/A
GBCI Yearly Profit, Operating, Gross MarginsGBCI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1

2. Health

2.1 Basic Checks

GBCI does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, GBCI has more shares outstanding
The number of shares outstanding for GBCI has been increased compared to 5 years ago.
Compared to 1 year ago, GBCI has an improved debt to assets ratio.
GBCI Yearly Shares OutstandingGBCI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
GBCI Yearly Total Debt VS Total AssetsGBCI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

2.2 Solvency

GBCI has a debt to FCF ratio of 6.50. This is a slightly negative value and a sign of low solvency as GBCI would need 6.50 years to pay back of all of its debts.
With a Debt to FCF ratio value of 6.50, GBCI is not doing good in the industry: 74.06% of the companies in the same industry are doing better.
GBCI has a Debt/Equity ratio of 0.63. This is a neutral value indicating GBCI is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.63, GBCI is not doing good in the industry: 79.85% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF 6.5
Altman-Z N/A
ROIC/WACCN/A
WACC10.38%
GBCI Yearly LT Debt VS Equity VS FCFGBCI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
GBCI Yearly Current Assets VS Current LiabilitesGBCI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

6

3. Growth

3.1 Past

GBCI shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 6.29%.
GBCI shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -7.00% yearly.
GBCI shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 8.46%.
The Revenue has been growing slightly by 5.61% on average over the past years.
EPS 1Y (TTM)6.29%
EPS 3Y-16.9%
EPS 5Y-7%
EPS Q2Q%65.52%
Revenue 1Y (TTM)8.46%
Revenue growth 3Y1.05%
Revenue growth 5Y5.61%
Sales Q2Q%14.12%

3.2 Future

The Earnings Per Share is expected to grow by 33.55% on average over the next years. This is a very strong growth
GBCI is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 15.09% yearly.
EPS Next Y34.89%
EPS Next 2Y33.55%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year15.89%
Revenue Next 2Y15.09%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
GBCI Yearly Revenue VS EstimatesGBCI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B
GBCI Yearly EPS VS EstimatesGBCI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4 5

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 24.83, the valuation of GBCI can be described as rather expensive.
Based on the Price/Earnings ratio, GBCI is valued expensively inside the industry as 83.88% of the companies are valued cheaper.
GBCI's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.30.
A Price/Forward Earnings ratio of 15.51 indicates a correct valuation of GBCI.
Based on the Price/Forward Earnings ratio, GBCI is valued a bit more expensive than the industry average as 74.31% of the companies are valued more cheaply.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.76, GBCI is valued a bit cheaper.
Industry RankSector Rank
PE 24.83
Fwd PE 15.51
GBCI Price Earnings VS Forward Price EarningsGBCI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of GBCI indicates a slightly more expensive valuation: GBCI is more expensive than 68.51% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 17.22
EV/EBITDA N/A
GBCI Per share dataGBCI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

GBCI's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as GBCI's earnings are expected to grow with 33.55% in the coming years.
PEG (NY)0.71
PEG (5Y)N/A
EPS Next 2Y33.55%
EPS Next 3YN/A

3

5. Dividend

5.1 Amount

GBCI has a Yearly Dividend Yield of 2.83%.
Compared to an average industry Dividend Yield of 3.31, GBCI has a dividend in line with its industry peers.
GBCI's Dividend Yield is a higher than the S&P500 average which is at 2.35.
Industry RankSector Rank
Dividend Yield 2.83%

5.2 History

The dividend of GBCI decreases each year by -1.00%.
GBCI has paid a dividend for at least 10 years, which is a reliable track record.
The dividend of GBCI decreased recently.
Dividend Growth(5Y)-1%
Div Incr Years0
Div Non Decr Years1
GBCI Yearly Dividends per shareGBCI Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1

5.3 Sustainability

GBCI pays out 70.77% of its income as dividend. This is not a sustainable payout ratio.
DP70.77%
EPS Next 2Y33.55%
EPS Next 3YN/A
GBCI Yearly Income VS Free CF VS DividendGBCI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M
GBCI Dividend Payout.GBCI Dividend Payout, showing the Payout Ratio.GBCI Dividend Payout.PayoutRetained Earnings

GLACIER BANCORP INC

NYSE:GBCI (7/11/2025, 8:17:39 PM)

After market: 46.19 0 (0%)

46.19

-0.47 (-1.01%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)04-24 2025-04-24/amc
Earnings (Next)07-24 2025-07-24/amc
Inst Owners81.19%
Inst Owner Change0%
Ins Owners0.45%
Ins Owner Change4.89%
Market Cap5.48B
Analysts81.67
Price Target49.3 (6.73%)
Short Float %2.85%
Short Ratio4.84
Dividend
Industry RankSector Rank
Dividend Yield 2.83%
Yearly Dividend1.34
Dividend Growth(5Y)-1%
DP70.77%
Div Incr Years0
Div Non Decr Years1
Ex-Date07-08 2025-07-08 (0.33)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1%
Min EPS beat(2)-0.47%
Max EPS beat(2)2.47%
EPS beat(4)3
Avg EPS beat(4)2.84%
Min EPS beat(4)-0.47%
Max EPS beat(4)5.76%
EPS beat(8)5
Avg EPS beat(8)3.09%
EPS beat(12)5
Avg EPS beat(12)0.42%
EPS beat(16)8
Avg EPS beat(16)1.64%
Revenue beat(2)0
Avg Revenue beat(2)-5.47%
Min Revenue beat(2)-7.71%
Max Revenue beat(2)-3.23%
Revenue beat(4)1
Avg Revenue beat(4)-3.16%
Min Revenue beat(4)-7.71%
Max Revenue beat(4)1.68%
Revenue beat(8)2
Avg Revenue beat(8)-2.06%
Revenue beat(12)6
Avg Revenue beat(12)1.2%
Revenue beat(16)10
Avg Revenue beat(16)4.71%
PT rev (1m)0%
PT rev (3m)-15.45%
EPS NQ rev (1m)-13.13%
EPS NQ rev (3m)-9.29%
EPS NY rev (1m)0%
EPS NY rev (3m)-1.48%
Revenue NQ rev (1m)3.48%
Revenue NQ rev (3m)-0.31%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-7.03%
Valuation
Industry RankSector Rank
PE 24.83
Fwd PE 15.51
P/S 6.37
P/FCF 17.22
P/OCF 14.89
P/B 1.66
P/tB 2.5
EV/EBITDA N/A
EPS(TTM)1.86
EY4.03%
EPS(NY)2.98
Fwd EY6.45%
FCF(TTM)2.68
FCFY5.81%
OCF(TTM)3.1
OCFY6.71%
SpS7.26
BVpS27.76
TBVpS18.48
PEG (NY)0.71
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.76%
ROE 6.45%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 24.68%
GM N/A
FCFM 36.96%
ROA(3y)0.87%
ROA(5y)1.03%
ROE(3y)7.98%
ROE(5y)8.89%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-13.51%
PM growth 5Y-7.22%
GM growth 3YN/A
GM growth 5YN/A
F-Score8
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF 6.5
Debt/EBITDA N/A
Cap/Depr 116.62%
Cap/Sales 5.78%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 149.73%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score8
WACC10.38%
ROIC/WACCN/A
Cap/Depr(3y)104.04%
Cap/Depr(5y)75.88%
Cap/Sales(3y)4.81%
Cap/Sales(5y)3.42%
Profit Quality(3y)153.47%
Profit Quality(5y)144.94%
High Growth Momentum
Growth
EPS 1Y (TTM)6.29%
EPS 3Y-16.9%
EPS 5Y-7%
EPS Q2Q%65.52%
EPS Next Y34.89%
EPS Next 2Y33.55%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)8.46%
Revenue growth 3Y1.05%
Revenue growth 5Y5.61%
Sales Q2Q%14.12%
Revenue Next Year15.89%
Revenue Next 2Y15.09%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-31.41%
FCF growth 3Y-28.03%
FCF growth 5Y-0.04%
OCF growth 1Y-25.14%
OCF growth 3Y-23.31%
OCF growth 5Y2.63%